India�s First MRNA Covid Vaccine By Gennova Granted Approval For Phase 2/3 Clinical Trails

[email protected]24 Sep, 2021News

India?s first mRNA-based COVID-19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for Phase 2/3 clinical trials, the Department of Biotechnology (DBT) said on Tuesday. The Pune-based biotechnology company had submitted the interim clinical data of the vaccine?s